Reply to R. Bhargava et al and K. Lambein et al

Affiliations

¹ The Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD.
² University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT.
³ University of Rochester Medical Center, Rochester, NY.
⁴ Royal Marsden Hospital, London, United Kingdom.
⁵ University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI.
⁶ National Cancer Institute, Bethesda, MD.

Comment

Antonio C Wolff et al. J Clin Oncol. 2014.

. 2014 Jun 10;32(17):1857-9.

doi: 10.1200/JCO.2014.55.0673. Epub 2014 Apr 28.

¹ The Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD.
² University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT.
³ University of Rochester Medical Center, Rochester, NY.
⁴ Royal Marsden Hospital, London, United Kingdom.
⁵ University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI.
⁶ National Cancer Institute, Bethesda, MD.

No abstract available

Comment on

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF; American Society of Clinical Oncology; College of American Pathologists. Wolff AC, et al. J Clin Oncol. 2007 Jan 1;25(1):118-45. doi: 10.1200/JCO.2006.09.2775. Epub 2006 Dec 11. J Clin Oncol. 2007. PMID: 17159189
2013 update of the American Society of Clinical Oncology/College of American Pathologists guideline for human epidermal growth factor receptor 2 testing: impact on immunohistochemistry-negative breast cancers.
Lambein K, Van Bockstal M, Denys H, Libbrecht L. Lambein K, et al. J Clin Oncol. 2014 Jun 10;32(17):1856-7. doi: 10.1200/JCO.2013.54.2530. Epub 2014 Apr 28. J Clin Oncol. 2014. PMID: 24778399 No abstract available.
Interpretation of human epidermal growth factor receptor 2 (HER2) in situ hybridization assays using 2013 update of American Society of Clinical Oncology/College of American Pathologists HER2 Guidelines.
Bhargava R, Dabbs DJ. Bhargava R, et al. J Clin Oncol. 2014 Jun 10;32(17):1855. doi: 10.1200/JCO.2013.53.9213. Epub 2014 Apr 28. J Clin Oncol. 2014. PMID: 24778404 No abstract available.